Ajanta Pharma - Quarterly Results
28th Jul 2022

The revenue for the June 2022 quarter is pegged at Rs. 8502.90 millions, about 14.48% up against Rs. 7427.20 millions recorded during the year-ago period.The Net proft of the company remain more or less same to Rs. 1503.70  millions from Rs. 1934.60 millions ,decline by -22.27%.Operating profit for the quarter ended June 2022 decreased to 2217.30 millions as compared to 2640.20 millions of corresponding quarter ended June 2021.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 8502.90 7427.20 14.48 8502.90 7427.20 14.48 31406.40 27185.90 15.52
Other Income 354.20 310.00 14.26 354.20 310.00 14.26 1397.30 1035.70 34.91
PBIDT 2217.30 2640.20 -16.02 2217.30 2640.20 -16.02 10306.20 10204.80 0.99
Interest 6.30 11.70 -46.15 6.30 11.70 -46.15 91.20 69.00 32.17
PBDT 2211.00 2628.50 -15.88 2211.00 2628.50 -15.88 10215.00 10135.80 0.78
Depreciation 307.50 297.60 3.33 307.50 297.60 3.33 1209.60 1114.90 8.49
PBT 1903.50 2330.90 -18.34 1903.50 2330.90 -18.34 9005.40 9020.90 -0.17
TAX 399.80 396.30 0.88 399.80 396.30 0.88 1806.80 2264.50 -20.21
Deferred Tax -18.30 32.60 -156.13 -18.30 32.60 -156.13 95.10 97.70 -2.66
PAT 1503.70 1934.60 -22.27 1503.70 1934.60 -22.27 7198.60 6756.40 6.54
Equity 257.10 173.90 47.84 257.10 173.90 47.84 171.70 173.90 -1.27
PBIDTM(%) 26.08 35.55 -26.64 26.08 35.55 -26.64 32.82 37.54 -12.58